相关实验视频
Updated: May 29, 2025

10:33
Generation of Alginate Microspheres for Biomedical Applications
Published on: August 12, 2012
20.7K
富科伊丹酸盐和硫酸酸盐微粒诱导不同的凝血,炎症和纤维性反应
Kalaiyarasi Vasuthas1,2, Joachim Sebastian Kjesbu3, Alessandro Brambilla2,4,5
1Centre of Molecular Inflammation Research (CEMIR), NTNU, Norway.
Materials today. Bio
|February 3, 2025
概括
富科伊丹酸盐微珠比硫酸酸盐微珠更容易引发炎症和纤维化. 等离子体活性和凝血之间的平衡,以及ECM降解蛋白酶,预测细胞治疗材料中的纤维化耐药性.
科学领域:
- 生物材料科学 生物材料科学
- 免疫学 免疫学 免疫学
- 蛋白质组学是指蛋白质组学.
背景情况:
- 酸微珠在细胞疗法中用于免疫保护.
- 硫酸酸盐微珠可以减少纤维化和炎症.
- 的多糖化合物富科伊丹 (Fucoidan) 尚未在微珠形式对其宿主反应进行评估.
研究的目的:
- 为了比较宿主对福科伊丹酸盐微珠的反应与硫酸酸盐微珠的反应.
- 评估蛋白质吸附,细胞因子概况和周囊细胞过度生长 (PFO).
- 为了确定预测纤维化耐药性的生物标志物.
主要方法:
- 人体全血和血测定蛋白质活性.
- 在C57BL/6JRj小鼠中评估外囊过度生长 (PFO).
- 液体染色学-双重质谱学 (LC-MS/MS) 蛋白质组学用于蛋白质模式映射.
主要成果:
- 富科伊丹阿尔金酸盐微珠激活补充和凝固,诱导更高的PFO.
- 这两种微珠类型都诱导了等离子体活性,但富可伊丹基酸盐微珠显示出明显的细胞因子概况 (增加了MCP-1,IL-8,IFN-γ;减少了RANTES,Eotaxin,PDGF-BB,TGF-β).
- 富科伊丹酸盐微珠丰富了细胞外矩阵因子,而硫酸酸盐微珠则有利于ECM降解蛋白酶.
结论:
- 宿主对富科伊丹和硫酸藻酸盐微珠的反应存在显著差异.
- 等离子体活性与凝血的比率是纤维化耐药性的关键指标.
- 在材料表面上丰富ECM降解蛋白酶对于缓解纤维化至关重要.
相关概念视频
Inflammatory Response II: Inflammatory Exudate and Tissue Repair
4.7K
The immune system's inflammatory response destroys the invading pathogen, permitting the tissue to heal. The changes during the cellular and vascular stages allow exudate formation at the site of inflammation. The inflammatory exudate released from the wound has high protein content and a specific gravity above 1.020.
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
The typical wound exudate is odorless, transparent, straw-colored, thin, and watery. Exudate, however, can differ depending on the state of wound healing. Likewise, the...
4.7K
Introduction to Hemostasis
5.2K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
5.2K
Clot Retraction and Fibrinolysis
3.6K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
3.6K

